BRITTNI HARRELL: Open Payments
NPI 1386124212 · THOMASVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,519 in 118 payments from 17 companies in 2025. Trend: 2023 $898 · 2024 $1,424 · 2025 $2,519
Food & beverage: $2,390Education: $129
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 28 | $570 |
| AstraZeneca Pharmaceuticals LP | 17 | $468 |
| Regeneron Healthcare Solutions, Inc. | 15 | $325 |
| Insmed, Inc. | 19 | $291 |
| GENZYME CORPORATION | 9 | $216 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $189 |
| Verona Pharma, Inc. | 5 | $104 |
| Pulmonx Corporation | 2 | $64 |
| Merck Sharp & Dohme LLC | 3 | $59 |
| Baxter Healthcare | 2 | $54 |
Products named: DUPIXENT, AIRSUPRA, NUCALA, TRELEGY ELLIPTA, Arikayce, OFEV, Ohtuvayre, FASENRA.
Industry payments across GA — which companies pay providers there.
